“Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial ” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s245. doi:10.25251/skin.7.supp.245.